ConductScience.org, home

Paper · 25755321

References131

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19030501Interventional therapeutic techniques in Budd-Chiari syndrome.Cardiovasc Intervent Radiol1997https://conductscience.org/library/papers/9030501PubMed
215726653Risk factors for thrombophilia in extrahepatic portal vein obstruction.Hepatology2005https://conductscience.org/library/papers/15726653PubMed
37203455Nodular transformation (nodular "regenerative" hyperplasia) of the liver. A clinicopathologic study of 30 cases.Hum Pathol1981https://conductscience.org/library/papers/7203455PubMed
413911165Obstruction to the extrahepatic portal system in childhood.Lancet1962https://conductscience.org/library/papers/13911165PubMed
58468654Side-to-side lienorenal shunt without splenectomy in noncirrhotic portal hypertension in children.J Pediatr Surg1993https://conductscience.org/library/papers/8468654PubMed
63259859Management of variceal bleeding in patients with noncirrhotic portal vein thrombosis.Ann Surg1988https://conductscience.org/library/papers/3259859PubMed
75088391Alterations of the intrahepatic vasculature in hepatosplenic schistosomiasis mansoni.Am J Trop Med Hyg1971https://conductscience.org/library/papers/5088391PubMed
83522373Hepatosplenic schistosomiasis: a clinical review.Gut1986https://conductscience.org/library/papers/3522373PubMed
99652458Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection.J Infect Dis1998https://conductscience.org/library/papers/9652458PubMed
103120350Possible HLA influence in governing susceptibility to non-cirrhotic portal fibrosis.Tissue Antigens1987https://conductscience.org/library/papers/3120350PubMed
117176846Liver pathology of idiopathic portal hypertension. Comparison with non-cirrhotic portal fibrosis of India. The Japan idiopathic portal hypertension study.Liver1982https://conductscience.org/library/papers/7176846PubMed
127737640Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients.Hepatology1995https://conductscience.org/library/papers/7737640PubMed
1315912047The utility of TIPS in the management of Budd-Chiari syndrome.Ann Surg2005https://conductscience.org/library/papers/15912047PubMed
141167315Vinyl-chloride-induced liver disease. From idiopathic portal hypertension (Banti's syndrome) to Angiosarcomas.N Engl J Med1975https://conductscience.org/library/papers/1167315PubMed
1512472938Non-cirrhotic portal hypertension versus idiopathic portal hypertension.J Gastroenterol Hepatol2002https://conductscience.org/library/papers/12472938PubMed
169641391Sonographic findings in noncirrhotic portal fibrosis.J Clin Ultrasound1998https://conductscience.org/library/papers/9641391PubMed
1710690535Serum tumor marker CA 125 is an early and sensitive indicator of veno-occlusive disease in children undergoing bone marrow transplantation.Clin Cancer Res2000https://conductscience.org/library/papers/10690535PubMed
188633575Hepatocellular carcinoma and nodular regenerative hyperplasia: possible pathogenetic relationship.Am J Gastroenterol1996https://conductscience.org/library/papers/8633575PubMed
19663882Pulmonary and hepatic granulomatous disorders due to the inhalation of cement and mica dusts.Thorax1978https://conductscience.org/library/papers/663882PubMed
209264006Increased incidence of glomerulonephritis following spleno-renal shunt surgery in non-cirrhotic portal fibrosis.Kidney Int1997https://conductscience.org/library/papers/9264006PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/25755321/references